156 related articles for article (PubMed ID: 2423549)
1. In vitro effects of an aromatase inhibitor on 5 alpha-reductase activity in human hypertrophic prostatic tissue.
Zoppi S; Cocconi M; Natali A; Costantini A; Serio M; Martini L; Motta M
J Clin Endocrinol Metab; 1986 Jul; 63(1):269-71. PubMed ID: 2423549
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1,4,6-androstatriene-3,17-dione (ATD), 4-hydroxy-4-androstene-3,17-dione (4-OH-A) and 4-acetoxy-4-androstene-3,17-dione (4-Ac-A) on the 5 alpha-reduction of androgens in the rat prostate.
Motta M; Zoppi S; Brodie AM; Martini L
J Steroid Biochem; 1986 Oct; 25(4):593-600. PubMed ID: 3773531
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of the 5 alpha-reductase of the rat epididymis.
Zoppi S; Lechuga M; Motta M
J Steroid Biochem Mol Biol; 1992 Jun; 42(5):509-14. PubMed ID: 1616880
[TBL] [Abstract][Full Text] [Related]
4. Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA.
Martel C; Trudel C; Couet J; Labrie C; Bélanger A; Labrie F
Mol Cell Endocrinol; 1993 Feb; 91(1-2):43-9. PubMed ID: 8472853
[TBL] [Abstract][Full Text] [Related]
5. Studies on the possible existence of two 5 alpha-reductases in the rat prostate.
Martini L; Zoppi S; Motta M
J Steroid Biochem; 1986 Jan; 24(1):177-82. PubMed ID: 3702403
[TBL] [Abstract][Full Text] [Related]
6. New approaches for the treatment of prostatic hypertrophy and cancer.
Zoppi S; Cocconi M; Serio M; Martini L; Motta M
Horm Res; 1987; 28(2-4):250-60. PubMed ID: 2456974
[TBL] [Abstract][Full Text] [Related]
7. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.
Délos S; Carsol JL; Ghazarossian E; Raynaud JP; Martin PM
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):375-83. PubMed ID: 8541234
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 5 alpha-reductase activity and alteration of nuclear testosterone. Dihydrotestosterone ratio in human genital skin fibroblasts.
Berkovitz GD; Brown TR; Migeon CJ
J Androl; 1984; 5(3):171-5. PubMed ID: 6746410
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies on the effect of cofactors on the 5 alpha-reductase and 3 alpha- and 3 beta-hydroxysteroid reductase activities in the hyperplastic human prostate.
Lombardo ME; Hakky SI; Hall MK; Hudson PB
J Urol; 1992 Nov; 148(5):1605-10. PubMed ID: 1279222
[TBL] [Abstract][Full Text] [Related]
10. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
[TBL] [Abstract][Full Text] [Related]
11. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
12. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
[TBL] [Abstract][Full Text] [Related]
13. Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism.
Brodie AM; Son C; King DA; Meyer KM; Inkster SE
Cancer Res; 1989 Dec; 49(23):6551-5. PubMed ID: 2479464
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of steroid 5 alpha-reductase from human skin fibroblasts by 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5 alpha-androstan-3-one.
Leshin M; Wilson JD
J Steroid Biochem; 1982 Sep; 17(3):245-50. PubMed ID: 6957692
[TBL] [Abstract][Full Text] [Related]
15. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
Smith CM; Ballard SA; Wyllie MG; Masters JR
J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
[TBL] [Abstract][Full Text] [Related]
16. Steroid metabolism by the lung: conversion of dihydrotestosterone to 5 alpha-androstan-3 alpha, 17 beta-diol by rat lung tissue in vitro.
Kao LW; Crosswell MJ; Weisz J
Endocrinology; 1979 Mar; 104(3):664-6. PubMed ID: 436725
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of luteinizing hormone (LH)-releasing hormone-induced secretion of LH in rat anterior pituitary cell culture by testosterone without conversion to 5 alpha-dihydrotestosterone.
Liang T; Brady EJ; Cheung A; Saperstein R
Endocrinology; 1984 Dec; 115(6):2311-7. PubMed ID: 6389095
[TBL] [Abstract][Full Text] [Related]
18. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
[TBL] [Abstract][Full Text] [Related]
19. Pathways and genes involved in steroid hormone metabolism in male pigs: a review and update.
Robic A; Faraut T; Prunier A
J Steroid Biochem Mol Biol; 2014 Mar; 140():44-55. PubMed ID: 24239507
[TBL] [Abstract][Full Text] [Related]
20. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
Ghanadian R; Puah CM
J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
